These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33098029)

  • 1. Serum potassium and heart failure: association, causation, and clinical implications.
    Sfairopoulos D; Arseniou A; Korantzopoulos P
    Heart Fail Rev; 2021 May; 26(3):479-486. PubMed ID: 33098029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom.
    Linde C; Bakhai A; Furuland H; Evans M; McEwan P; Ayoubkhani D; Qin L
    J Am Heart Assoc; 2019 Nov; 8(22):e012655. PubMed ID: 31711387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of RAASi-associated hyperkalemia in patients with cardiovascular disease.
    Silva-Cardoso J; Brito D; Frazão JM; Ferreira A; Bettencourt P; Branco P; Fonseca C
    Heart Fail Rev; 2021 Jul; 26(4):891-896. PubMed ID: 33599908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High- Versus Low-dose Losartan and Serum Potassium: An Analysis From HEAAL.
    Ferreira JP; Konstam M; Rossignol P; Kiernan MS; Zannad F
    J Card Fail; 2023 Jan; 29(1):45-52. PubMed ID: 36244652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans.
    Matsushita K; Sang Y; Yang C; Ballew SH; Grams ME; Coresh J; Molnar MZ
    PLoS One; 2019; 14(8):e0219899. PubMed ID: 31393910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK.
    Linde C; Qin L; Bakhai A; Furuland H; Evans M; Ayoubkhani D; Palaka E; Bennett H; McEwan P
    ESC Heart Fail; 2019 Apr; 6(2):280-290. PubMed ID: 30629342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a health economic model to evaluate the potential benefits of optimal serum potassium management in patients with heart failure.
    Bakhai A; Palaka E; Linde C; Bennett H; Furuland H; Qin L; McEwan P; Evans M
    J Med Econ; 2018 Dec; 21(12):1172-1182. PubMed ID: 30160541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Savarese G; Xu H; Trevisan M; Dahlström U; Rossignol P; Pitt B; Lund LH; Carrero JJ
    JACC Heart Fail; 2019 Jan; 7(1):65-76. PubMed ID: 30553905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.
    Butler J; Anker SD; Lund LH; Coats AJS; Filippatos G; Siddiqi TJ; Friede T; Fabien V; Kosiborod M; Metra M; Piña IL; Pinto F; Rossignol P; van der Meer P; Bahit C; Belohlavek J; Böhm M; Brugts JJ; Cleland JGF; Ezekowitz J; Bayes-Genis A; Gotsman I; Goudev A; Khintibidze I; Lindenfeld J; Mentz RJ; Merkely B; Montes EC; Mullens W; Nicolau JC; Parkhomenko A; Ponikowski P; Seferovic PM; Senni M; Shlyakhto E; Cohen-Solal A; Szecsödy P; Jensen K; Dorigotti F; Weir MR; Pitt B
    Eur Heart J; 2022 Nov; 43(41):4362-4373. PubMed ID: 35900838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of hyperkalemia and RAASi nonadherence on patients affected by heart failure or chronic kidney disease].
    Degli Esposti L; Perrone V; Giacomini E; Sangiorgi D; Alessandrini D; Santoro A
    G Ital Nefrol; 2019 Sep; 36(5):. PubMed ID: 31580544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review.
    Ferreira JP; Butler J; Rossignol P; Pitt B; Anker SD; Kosiborod M; Lund LH; Bakris GL; Weir MR; Zannad F
    J Am Coll Cardiol; 2020 Jun; 75(22):2836-2850. PubMed ID: 32498812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between serum potassium levels and all-cause mortality in patients with acute heart failure].
    Huang BP; Zhou Q; Zhao L; Zhao XM; Zhai M; Tian PC; Liang L; Huang LY; Feng JY; Zhang YH; Huang Y; Zhang J
    Zhonghua Yi Xue Za Zhi; 2023 Mar; 103(10):727-732. PubMed ID: 36889685
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system.
    Nilsson E; Gasparini A; Ärnlöv J; Xu H; Henriksson KM; Coresh J; Grams ME; Carrero JJ
    Int J Cardiol; 2017 Oct; 245():277-284. PubMed ID: 28735756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR; Rolfe M
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.
    Desai AS; Liu J; Pfeffer MA; Claggett B; Fleg J; Lewis EF; McKinlay S; O'Meara E; Shah SJ; Sweitzer NK; Solomon S; Pitt B
    J Card Fail; 2018 May; 24(5):313-320. PubMed ID: 29572190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between serum potassium and adverse clinical outcomes: A systematic literature review.
    Palaka E; Grandy S; Darlington O; McEwan P; van Doornewaard A
    Int J Clin Pract; 2020 Jan; 74(1):e13421. PubMed ID: 31532067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients.
    Bouadma L; Mankikian S; Darmon M; Argaud L; Vinclair C; Siami S; Garrouste-Orgeas M; Papazian L; Cohen Y; Marcotte G; Styfalova L; Reignier J; Lautrette A; Schwebel C; Timsit JF;
    Crit Care; 2019 Dec; 23(1):415. PubMed ID: 31856891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperkalemia in heart failure: Foe or friend?
    Rakisheva A; Marketou M; Klimenko A; Troyanova-Shchutskaia T; Vardas P
    Clin Cardiol; 2020 Jul; 43(7):666-675. PubMed ID: 32445223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperkalemia in heart failure: etiology, epidemiology and prognosis].
    Romani S; Sinagra G
    G Ital Cardiol (Rome); 2021 Dec; 22(12 Suppl 1):e3-e7. PubMed ID: 34935773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.
    Collins AJ; Pitt B; Reaven N; Funk S; McGaughey K; Wilson D; Bushinsky DA
    Am J Nephrol; 2017; 46(3):213-221. PubMed ID: 28866674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.